INSIGHTS ON DRUG DEVELOPMENT

• Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs

  The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

• Targeted Modalities Set Elevated Standards For Precision

  Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight

  By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

• 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems

  3/10/2025

  Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

• How To Power MRD Assessment And Multi-Cancer Detection Research

  6/25/2026

  New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.

• Sustainability In On-Body Delivery System Platforms

  7/2/2026

  Explore how our on-body delivery system supports high-volume biologic delivery by balancing usability, patient needs, and sustainability through research-driven design.

• Assessing Viability And Real-Time Apoptosis/Necrosis

  3/17/2025

  Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.

• Making Accelerated Predictive Stability Studies Even Faster With Software

  6/18/2026

  Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.